Sugi Predict

Sugi Predict / Compounds / SCHEMBL2164137

SCHEMBL2164137

SCHEMBL2164137

O=C(CCc1ccccc1)Nc1ccc(CCC(=O)Nc2ccc3cnccc3c2)cc1

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PRMT3 O60678 1/20 0.69
▸ LMNA P02545 1/20 0.67
▸ IMPDH2 P12268 2/20 0.66
▸ PLAU P00749 1/20 0.60
▸ MAPT P10636 2/20 0.58
▸ HTT P42858 1/20 0.58
▸ NPY5R Q15761 1/20 0.58
▸ GAA P10253 1/20 0.58
▸ TOP2A P11388 1/20 0.58
▸ TOP2B Q02880 1/20 0.58
▸ NOTUM Q6P988 2/20 0.57
▸ ROCK1 Q13464 3/20 0.56
▸ ROCK2 O75116 5/20 0.56
▸ NAMPT P43490 1/20 0.56
▸ KDM6B O15054 1/20 0.55
▸ KDM4D Q6B0I6 1/20 0.55
▸ KDM4C Q9H3R0 1/20 0.55
▸ EGLN3 Q9H6Z9 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3566775 0.97 PRMT3 (0.72) PRMT3LMNAIMPDH2PLAUMAPT
SCHEMBL14124401 0.91 IMPDH2 (0.61) PRMT3LMNAIMPDH2PLAUMAPT
SCHEMBL14124306 0.90 PRMT3 (0.66) PRMT3LMNAIMPDH2PLAUMAPT
SCHEMBL19860082 0.88 ROCK1 (0.60) PRMT3LMNAIMPDH2NOTUMROCK1
SCHEMBL18092568 0.87 ROCK2 (0.59) PRMT3LMNAIMPDH2NOTUMROCK1
SCHEMBL14124391 0.86 LMNA (0.63) PRMT3LMNAIMPDH2MAPTROCK1
SCHEMBL14124389 0.86 JAK2 (0.62) PRMT3LMNAIMPDH2MAPTHTT
SCHEMBL24735962 0.86 IMPDH2 (0.69) PRMT3IMPDH2NOTUMROCK1ROCK2
SCHEMBL19860123 0.84 IMPDH2 (0.71) PRMT3IMPDH2NOTUMROCK1ROCK2
SCHEMBL19860083 0.84 PRMT3 (0.53) PRMT3IMPDH2NOTUMROCK1ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10899714-B2 6-aminoisoquinoline compounds AERIE PHARMACEUTICALS, INC. (US) 2021-01-26 — — US disclosed
US-20200181090-A1 6-AMINOISOQUINOLINE COMPOUNDS ALCON INC. (CH) 2020-06-11 — — US disclosed
US-20200181090-A1 6-AMINOISOQUINOLINE COMPOUNDS ALCON INC. (CH) 2020-06-11 — — US disclosed
US-10472327-B2 6-aminoisoquinoline compounds AERIE PHARMACEUTICALS, INC. (US) 2019-11-12 — — US disclosed
US-10472327-B2 6-aminoisoquinoline compounds AERIE PHARMACEUTICALS, INC. (US) 2019-11-12 — — US disclosed
US-20180186746-A1 6-AMINOISOQUINOLINE COMPOUNDS ALCON INC. (CH) 2018-07-05 — — US disclosed
US-20180186746-A1 6-AMINOISOQUINOLINE COMPOUNDS ALCON INC. (CH) 2018-07-05 — — US disclosed
US-9890123-B2 6-aminoisoquinoline compounds AERIE PHARMACEUTICALS, INC. (US) 2018-02-13 — — US disclosed
US-9890123-B2 6-aminoisoquinoline compounds AERIE PHARMACEUTICALS, INC. (US) 2018-02-13 — — US disclosed
US-20160280656-A1 6-AMINOISOQUINOLINE COMPOUNDS ALCON INC. (CH) 2016-09-29 — — US disclosed
US-7671205-B2 6-aminoisoquinoline compounds AERIE PHARMACEUTICALS, INC. (US) 2010-03-02 — — US disclosed
EP-2118064-A2 6-AMINOISOQUINOLINE COMPOUNDS USEFUL AS KINASE MODULATORS AERIE PHARMACEUTICALS, INC. (US) 2009-11-18 — — EP disclosed
WO-2008086269-A2 6-AMINOISOQUINOLINE COMPOUNDS USEFUL AS KINASE MODULATORS AERIE PHARMACEUTICALS, INC. (US) 2008-07-17 — — WO disclosed
WO-2008086269-A2 6-AMINOISOQUINOLINE COMPOUNDS USEFUL AS KINASE MODULATORS AERIE PHARMACEUTICALS, INC. (US) 2008-07-17 — — WO disclosed
US-20080167340-A1 6-Aminoisoquinoline Compounds AERIE PHARMACEUTICALS, INC. (US) 2008-07-10 — — US disclosed
US-20080167340-A1 6-Aminoisoquinoline Compounds AERIE PHARMACEUTICALS, INC. (US) 2008-07-10 — — US disclosed
US-20080167340-A1 6-Aminoisoquinoline Compounds AERIE PHARMACEUTICALS, INC. (US) 2008-07-10 — — US disclosed
US-20070173530-A1 6-Aminoisoquinoline Compounds AERIE PHARMACEUTICALS, INC. (US) 2007-07-26 — — US disclosed
US-20070173530-A1 6-Aminoisoquinoline Compounds AERIE PHARMACEUTICALS, INC. (US) 2007-07-26 — — US disclosed
US-20070173530-A1 6-Aminoisoquinoline Compounds AERIE PHARMACEUTICALS, INC. (US) 2007-07-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160280656-A1 6-AMINOISOQUINOLINE COMPOUNDS COQ8A, PGC, AGK PRMT3 1026/4885LMNA 2665/4885IMPDH2 2131/4885
US-20200181090-A1 6-AMINOISOQUINOLINE COMPOUNDS COQ8A, PGC, AGK PRMT3 1026/4885LMNA 2665/4885IMPDH2 2131/4885
US-20080167340-A1 6-Aminoisoquinoline Compounds COQ8A, PGC, AGK PRMT3 1026/4885LMNA 2665/4885IMPDH2 2131/4885
US-10472327-B2 6-aminoisoquinoline compounds COQ8A, PGC, AGK PRMT3 1026/4885LMNA 2665/4885IMPDH2 2131/4885
US-10899714-B2 6-aminoisoquinoline compounds COQ8A, PGC, AGK PRMT3 1026/4885LMNA 2665/4885IMPDH2 2131/4885
US-20070173530-A1 6-Aminoisoquinoline Compounds COQ8A, PGC, AGK PRMT3 1026/4885LMNA 2665/4885IMPDH2 2131/4885
US-20180186746-A1 6-AMINOISOQUINOLINE COMPOUNDS COQ8A, PGC, AGK PRMT3 1026/4885LMNA 2665/4885IMPDH2 2131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.